Hosted on MSN
Novartis fails in bid to block MSN Pharma’s generic Entresto as court denies injunction
A federal judge in New Jersey denied a preliminary injunction sought by Novartis (NYSE:NVS) to block MSN Pharmaceuticals from launching a generic version of the former’s blockbuster heart failure ...
Swiss pharmaceutical giant Novartis has agreed to buy biotechnology company Avidity Biosciences for about $12 billion, the company said Sunday. Novartis will pay Avidity shareholders $72 a share in ...
The Swiss drugmaker announced its biggest deal in a decade on Sunday, as its set to buy Avidity Biosciences for about $12 billion. "We have adequate firepower to do deals like this and to bolster the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results